Sumitomo Pharma Co. Ltd.

In News

Sumitomo Pharma Co Ltd - Notice regarding determination of issue price, selling price and other matters - marketscreener.com

marketscreener.com - Apr 20, 2026

Kyowa Kirin Co Ltd (4151) - MSN

MSN - Apr 21, 2026

Sumitomo Pharma Co Ltd - Will Conduct New Share Offering - TradingView

TradingView - Apr 08, 2026

Sumitomo Pharma Hits Day High with 7.54% Surge in Stock Price - Markets Mojo

Markets Mojo - Apr 19, 2026

Did Sumitomo Pharma’s (TSE:4506) New Share and Secondary Offering Plan Just Reframe Its Investment Narrative? - simplywall.st

simplywall.st - Apr 09, 2026

Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis - PR Newswire

PR Newswire - Jul 30, 2025

Sumitomo Pharma shares slide nearly 16% despite panel backing for iPS-derived parkinson’s treatment - Seeking Alpha

Seeking Alpha - Feb 20, 2026

Sumitomo Pharma to Raise Capital via Major Share Offering While Remaining Sumitomo Chemical Subsidiary - The Globe and Mail

The Globe and Mail - Apr 09, 2026

Cytonome Congratulates Sumitomo Pharma on Regulatory Approval for Regenerative Medicine Therapy for Parkinson’s disease - BioInformant

BioInformant - Mar 11, 2026

New muscarinic M4 receptor antagonists reported in Sumitomo Pharma patent - BioWorld News

BioWorld News - Mar 02, 2026

Sumitomo Pharma Shares Drop After Stem-Therapy Backing - Bloomberg.com

Bloomberg.com - Feb 19, 2026

Sumitomo Pharma Refinances Guaranteed Debt With New Bridge Loan - TipRanks

TipRanks - Apr 08, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment